CLINICAL ROLE -
The Promise of RNA Interference (RNAi) Therapies: Revolutionizing Medicine
The ability to selectively silence or downregulate specific genes has opened new avenues for treating a myriad of diseases.
Read More
Zilebesiran Offers An RNA Interference Therapeutic Agent for Hypertension
The potential for RNAi to offer targeted and sustained control of blood pressure may represent a transformative approach in the broader landscape of cardiovascular therapeutics.
Zavegepant Is A Promising Frontier in Acute Migraine Treatment
As a CGRP receptor antagonist, zavegepant intervenes during the active phase of migraine, providing a targeted and prompt response to alleviate symptoms.
Cardiovascular Outcomes in Patients Intolerant to Statins Treated with Bempedoic Acid
In December 2023, the FDA granted expanded indications for bempedoic acid and bempedoic acid plus ezetimibe in the treatment of primary hyperlipidemia.
Gepirone Offers New Option for Major Depressive Disorder
Gepirone does not induce sexual dysfunction, a common limitation associated with SSRIs.
Pharmacists Play Crucial Role in Antimicrobial Stewardship
Available data indicate that as much as 50% of all antibiotics prescribed for individuals may be either unnecessary or not administered in the most effective manner as recommended.